Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human LDLR Protein, N-His

Catalog #:   YHB91301 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P01130
Protein length: Thr497-Thr742
Overview

Catalog No.

YHB91301

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Thr497-Thr742

Predicted molecular weight

29.54 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P01130

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

LDLR, Low-density lipoprotein receptor, LDL receptor

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human LDLR protein
References

Fibrogenic Gene Signature as Early Prediction for the Efficacy of Pharmacological Interventions for MASH-Associated Fibrosis., PMID:40515541

LDL receptor-mediated endocytosis of Escherichia coli α-hemolysin mediates renal epithelial toxicity., PMID:40504153

Long-term experience with lomitapide treatment in patients with homozygous familial hypercholesterolemia: Over 10 years of efficacy and safety data., PMID:40494715

PCSK9 inhibition mitigates vulnerable plaque formation induced by hyperhomocysteinemia through regulating lipid metabolism and inflammation., PMID:40480522

Transcriptomics characteristics and differentiation of subcutaneous adipose tissue among Huainan pigs and its hybrid genetic populations., PMID:40475027

AAV8-LDLR Gene Therapy in Ldlr-KO and Homozygous Ldlr p.W483X Mice., PMID:40462752

A rare gain of function variant of hepatic lipase attenuates hypercholesterolemia and atherosclerosis in mice via an LDL receptor-independent mechanism., PMID:40460236

Cholesterol-induced colorectal cancer progression and its mitigation through gut microbiota remodeling and simvastatin treatment., PMID:40452015

Hypercholesterolemia Duration and Brain Area Determine Inflammatory Response Intensity and Apoptotic Mediator Activation in Apo E-/-/LDLR-/- Double-Knockout Mice., PMID:40445431

Exploring the pathways linking fasting insulin to coronary artery disease: a proteome-wide Mendelian randomization study., PMID:40442727

Functionalized Boron Carbide Nanoparticles as Active Boron Delivery Agents Dedicated to Boron Neutron Capture Therapy., PMID:40438187

Marein from Coreopsis tinctoria Nutt. alleviates oxidative stress and lipid accumulation via SIRT1/Nrf2 signaling., PMID:40437103

Anti-inflammatory, but not lipid-lowering, activity of hepatocyte PPARα improves atherosclerosis in Ldlr-deficient mice., PMID:40435217

Ertugliflozin attenuates atherosclerosis in nondiabetic ApoE-/- mice by upregulating ABCA1 and LDLR via the PPARγ/LXRα pathway., PMID:40419168

Integrating Mendelian randomization and multi-transcriptomic analyses to unveil the genetic association risk of regulatory T cell-mediated free cholesterol and gastric cancer., PMID:40405007

Strontium regulating lipid metabolism of bovine hepatocytes via SIRT1/SREBPs pathway., PMID:40403884

Structural basis for the recognition of two different types of receptors by Western equine encephalitis virus., PMID:40402741

Selected cell receptor genotypes differentially modulate the ABO blood group influence on Factor VIII levels in severe aortic stenosis., PMID:40398046

ASGR1 inhibitors, inflammation, and heart failure: A Mendelian randomization analysis., PMID:40391737

Structural dynamics of LDL receptor interactions with E498A and R499G variants of PCSK9., PMID:40388017

Negative Impact of Caloric Restriction on Atherosclerosis in Young ApoE/LDLr -/- Mice., PMID:40384342

Quantitative proteomic analysis of the protective effect exerted by alliin on ox-LDL-injured HUVECs., PMID:40379781

Asparagine endopeptidase cleaves apolipoprotein A1 and accelerates pathogenesis of atherosclerosis., PMID:40371638

IL-19 Is a Novel Lymphangiocrine Factor Inducing Lymphangiogenesis and Lymphatic Junctional Regulation., PMID:40371466

(-)-Oleuropein as a Novel Metastatic Castration-Resistant Prostate Cancer Progression and Recurrence Suppressor via Targeting PCSK9-LDLR Axis., PMID:40362754

Epigenetic Modifications in Alternative Splicing of LDLR pre-mRNA on Hypercholesterolemia Following Aerobic Exercise Training., PMID:40362496

Accelerated atherosclerosis associated with immune checkpoint inhibitors: a systematic review and meta-analysis of pre-clinical studies., PMID:40354680

Lanatoside C, a Novel Senolytic, Ameliorates Atherosclerosis in Mice., PMID:40354378

Design of lipid nanoparticle (LNP) containing genetic material CRISPR/Cas9 for familial hypercholesterolemia., PMID:40352243

[Clinical manifestations and genetic analysis of two patients with familial hypercholesterolemia caused by complex heterozygous variants]., PMID:40350401

The LDL receptor-related protein 1 (LRP1) facilitates ACE2-mediated endocytosis of SARS-CoV2 spike protein-containing pseudovirions., PMID:40349772

Decreased protein activator of interferon induced protein kinase (PRKRA) involved in menopause-related cholesterol metabolic disorders by regulating cholesterol biosynthesis., PMID:40349061

Resveratrol improved atherosclerosis by increasing LDLR levels via the EGFR-ERK1/2 signaling pathway., PMID:40340973

Homozygous familial hypercholesterolemia evaluation and survival single center study in Saudi Arabia: The HESSA registry., PMID:40339360

Kratom leaf extracts exert hypolipidaemic effects via the modulation of PCSK9 and LDLR pathways in HepG2 cells., PMID:40325086

Effect of dexamethasone on biological properties and metabolic adaptations of normal prostate epithelial cells under mild serum conditions., PMID:40316041

The role of gut microbiota on skeletal muscle strength in LDLR knockdown aging mice., PMID:40312444

Hypercholesterolemia drives microglial dysfunction and weakens response to amyloid plaques., PMID:40286863

Involvement of cholesterol and ketone bodies in early stages of bovine cystic ovarian disease development., PMID:40286443

A Novel Screening Approach for Familial Hypercholesterolemia: A Genetic Study on Patients Detected Using Preexisting Centralized Analytics., PMID:40283609

Gastrodin attenuates hypercholesterolaemia through regulating the PCSK9/LDLR signalling pathway by suppressing HNF-1α and activating FoxO3a., PMID:40279963

Fibroblast Activation Protein Compared with Other Markers of Activated Smooth Muscle Cells, Extracellular Matrix Turnover and Inflammation in a Mouse Model of Atherosclerosis., PMID:40278373

Attenuation of Atherosclerosis With PAR4 Deficiency: A Potential Role of Hematopoietically Expressed PAR4 in Atherosclerosis-Brief Report., PMID:40270259

Hepatoprotective and Antiatherosclerotic Effects of Oleoylethanolamide-Based Dietary Supplement in Dietary-Induced Obesity in Mice., PMID:40265441

Macrophage caspase-8 inhibition accelerates necrotic core expansion in atheroma plaque in mice., PMID:40264785

Variants in candidate genes and their interactions with smoking on the risk of acute coronary syndrome., PMID:40257950

Amelioration of atherosclerotic complications and dyslipidemia by verbascoside-enriched fraction of Clerodendrum glandulosum leaves targeting LDL-R and LXR-mediated reverse cholesterol transport., PMID:40256711

An Updated Review of Potential Drug Targets for Japanese Encephalitis., PMID:40247803

LDLR-targeted orlistat therapeutic nanoparticles: Peptide selection, assembly, characterization, and cell-uptake in breast cancer cell lines., PMID:40239877

Sesamin regulates breast cancer through reprogramming of lipid metabolism., PMID:40233124

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human LDLR Protein, N-His [YHB91301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only